You have accessJournal of UrologySexual Function/Dysfunction: Evaluation II1 Apr 2018MP74-16 MEASURING SEXUAL FUNCTION AFTER TREATMENT FOR PROSTATE CANCER IN MEN WHO HAVE SEX WITH MEN: A HIDDEN DOMAIN EMERGES Channa Amarasekera, Vincent Wong, James Burns, Kyle Tsai, David Victorson, and Shilajit Kundu Channa AmarasekeraChanna Amarasekera More articles by this author , Vincent WongVincent Wong More articles by this author , James BurnsJames Burns More articles by this author , Kyle TsaiKyle Tsai More articles by this author , David VictorsonDavid Victorson More articles by this author , and Shilajit KunduShilajit Kundu More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2018.02.2400AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Treatment for prostate cancer (PCa) can lead to significant impairments in sexual function (SF). Assessing SF both pre- and post-treatment provides an assessment of baseline function and helps measure progress with recovery. Several validated questionnaires exist for measuring SF. However, these instruments were validated using cohorts of men that were predominantly heterosexual. Men who have sex with men (MSM) have different sexual repertoires compared to heterosexual men (HSM) and current instruments may not apply to this population. Our objective was to determine if there are SF domains relevant to MSM that are missed by existing tools. METHODS We administered an online self-reported questionnaire to a cohort of 618 men from across the US (285 MSM, 333 HSM) regarding the applicability of the sexual function domain in the validated Expanded Prostate Cancer Index Composite (EPIC) questionnaire. These men were then queried about areas of concern in SF that may have missed by this instrument. Continuous variables were analyzed with a t-test, and a chi-square test was utilized for categorical variables. RESULTS The two cohorts were well matched with regard to demographics, including age, race, and education. MSM and HSM found EPIC-SF equally applicable at measuring erectile function (72.61% of MSM and 73.34% of HSM, p=.74). With regard to currently unmeasured domains, a larger number of MSM felt that prostate stimulation was a source of sexual satisfaction for the receptive partner during receptive anal intercourse (RAI) compared to HSM (61.9% vs. 12.77%, p<.0001). A larger proportion of MSM also felt it important to measure sexual satisfaction with RAI when assessing sexual function after PCa treatment (50.0% MSM vs. 12.2% HSM, p=.0002). When stratifying for MSM who engaged in RAI in the preceding year (MSM-RAI) vs. MSM who did not, a larger proportion of MSM-RAI felt that prostate stimulation was a source of sexual satisfaction during RAI (87.5% vs. 66.3%, p=.001), and more MSM-RAI thought it important to measure sexual satisfaction as it relates to RAI after PCa treatment (75.3% vs. 53.94%, p<.001). CONCLUSIONS Currently used instruments measuring SF are applicable to MSM and HSM with regard to erectile function, but fail to measure sexual satisfaction as it relates to RAI, an important area of sexual function for MSM, particularly in MSM who engage in RAI. Our findings highlight the need to add a domain relating to sexual satisfaction from RAI, to help care for and follow sexual minorities treated for PCa. © 2018FiguresReferencesRelatedDetails Volume 199Issue 4SApril 2018Page: e1005-e1006 Advertisement Copyright & Permissions© 2018MetricsAuthor Information Channa Amarasekera More articles by this author Vincent Wong More articles by this author James Burns More articles by this author Kyle Tsai More articles by this author David Victorson More articles by this author Shilajit Kundu More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...